CADTH | Search

Current Filters

Showing 51 - 60 results of 3551

Tafinlar for Metastatic Melanoma - Details (Tafinlar) (Last Updated: Dec 20, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Tafinlar
Manufacturer:
GlaxoSmithKline
Submission Type:
Initial

New at CADTH — August 2022 (Last Updated: Aug 8, 2022)

Corporate News and Events CADTH Symposium: Springing Back to Spring in 2023 CADTH is preparing to bring back the usual time frame of the CADTH Symposium to the spring. Unfortunately, this means there...
Project Line:
New at CADTH

Real-World Data Multistakeholder Strategy (Last Updated: Sep 6, 2022)

Understanding the perspective of different stakeholders and their information needs from the earliest stages of the drug life cycle can both enhance and streamline decision-making processes. Early...
Project Line:
Methods and Guidelines
Download results as CSV